Introduction to Versavo 100mg Injection:

VERSAVO 100MG INJECTION contains Bevacizumab which belongs to the group of medicines called Antineoplastic agents. It is used in adult patients with Fluoropyrimidine (chemotherapy medicine) to treat metastatic cancer in large bowel (colon or rectum). It is also used with Paclitaxel/ Capecitabine (chemotherapy medicine) to treat metastatic breast cancer in adult patients.

VERSAVO 100MG INJECTION is used with chemotherapy regimen containing Platinum to treat advanced non-small cell lung cancer without epidermal growth factor receptor (mutated protein responsible to cause cancer in a cell) and with Erlotinib (chemotherapy medicine) to treat metastatic non-small cell lung cancer with epidermal growth factor receptor (in cancer cells) in adult patients. The medicine is indicated for use to treat metastatic kidney cancer along with interferon (chemotherapy medicine) which is also indicated for use with Carboplatin, Gemcitabine, and/or with Carboplatin and Paclitaxel (chemotherapy medicine) to treat recurrent advanced epithelial ovarian, fallopian tube/primary peritoneal cancer in adult patients. The medicine is also used to treat persistent, recurrent or metastatic cervical cancer with/without Paclitaxel and Cisplatin/ Paclitaxel and Topotecan in adult patients.

Uses of Versavo 100mg Injection:

Cancer of colon and rectum

Non-small cell lung cancer

Cervical cancer

Ovarian cancer

Cancer of fallopian tube

Brain tumor

Kidney cancer

How to use Versavo 100mg Injection:

Your physician or nurse will administer Versavo 100mg Injection as an intravenous infusion. The infusion should be given immediately after the dilution.